Akebia Therapeutics, Inc. (AKBA): Nasdaq/NYSE listing notice — Akebia receives Nasdaq delisting notice for bid price non-compliance; plans appeal

Akebia Therapeutics, Inc.

Notified May 9, 2023 for failing minimum bid price (Rule 5550(a)(2)) after second 180-day grace period expired May 8, 2023.
Company will request a hearing before Nasdaq Hearings Panel, which stays delisting pending panel decision.
If delisted, expects common stock to be eligible for trading on OTC Markets platform.
Previous grace periods granted May 2022 and Nov 2022; company did not regain compliance by May 8, 2023.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Akebia Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

May 9, 2023, Akebia Therapeutics, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based upon the Company’s non-compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as of May 8, 2023, the Company’s securities were subject to delisting unless the Company timely appeals the Staff’s determination by requesting a hearing before the Nasdaq Hearings Panel (the “Panel”). The Company plans to timely request a hearing before the Panel, which request will stay any

View on SEC.gov

Browse all listing & compliance notices →

Akebia Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-139506

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.